The health services industry closed the day up 0.3%. Amedisys Inc ( AMED), Oculus Innovative Sciences Inc ( OCLS), SRI Surgical Express Inc ( STRC), and Fonar Corporation ( FONR) were all winners today within the health services industry with Pharmaceutical Product Development Inc ( PPDI) being today's featured health services winner. Pharmaceutical Product Development Inc rose $1.04 (4.1%) to $26.22 on average volume. Throughout the day, 1.5 million shares of Pharmaceutical Product Development Inc exchanged hands as compared to its average daily volume of 1.5 million shares.

Pharmaceutical Product Development, Inc., a contract research organization, provides drug discovery, development, and lifecycle management services. It operates in two segments, Development and Laboratory Services. Pharmaceutical Product Development Inc has a market cap of $2.9 billion and is part of the health care sector. The company has a P/E ratio of 41, above the average health services industry P/E ratio of 17.9 and above the S&P 500 P/E ratio of 17.7. Shares are down 7.2% year to date as of the close of trading on Wednesday.

TheStreet Ratings rates Pharmaceutical Product Development as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, compelling growth in net income, revenue growth, reasonable valuation levels and notable return on equity. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.

On the negative front, Escalon Medical Corporation ( ESMC), Dynacq Healthcare Inc ( DYII), Pressure BioSciences Inc ( PBIO), and Edap TMS ( EDAP) were all losers within the health services industry with MAKO Surgical Corporation ( MAKO) being today's health services industry Loser Spotlight stock.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).
null

If you liked this article you might like

Pharmaceutical Product Development Reaches New 52-Week High (PPDI)

Pharmaceutical Product Development Reaches New 52-Week High (PPDI)

7 Stocks Hitting New 52-Week Highs

7 Stocks Hitting New 52-Week Highs

Pharmaceutical Product Development Inc. (PPDI): Today's Featured Health Services Winner

Pharmaceutical Product Development Inc. (PPDI): Today's Featured Health Services Winner

PPDI Inks $3.9 Billion PE Buyout (Update 1)

PPDI Inks $3.9 Billion PE Buyout (Update 1)

Pharmaceutical Product Development Stock Soars (PPDI)

Pharmaceutical Product Development Stock Soars (PPDI)